Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Re: The Monarch Bay Way.
WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE
REQUESTED NOT TO SEND US A PROXY.
Your vote or consent is not requested or required to approve these matters. The accompanying Information Statement is provided solely for your information.
http://www.sec.gov/Archives/edgar/data/936446/000112178109000431/paosdef14c102009.htm
David Walters
Mr. Walters co-founded Monarch Bay Associates, LLC, a FINRA registered broker dealer, in 2006. Prior to Monarch Bay Associates, Mr. Walters was a principal with Monarch Bay Capital Group, LLC, a firm that provided advisory services and capital for emerging growth companies. From 1992 through 2000, he was Executive Vice President and Managing Director in charge of capital markets for Roth Capital (formerly Cruttenden Roth), where he managed the Capital Markets group and led over 100 financings (public and private), raising over $2 billion in growth capital. Additionally, Mr. Walters oversaw a research department that covered over 100 public companies and was responsible for the syndication, distribution and after-market trading of the public offerings. He managed the public offerings for Cruttenden Roth, which was the most prolific public underwriter in the U.S. for deals whose post-offering market cap was less than $100 million. Mr. Walters sat on Roth's Board of Directors from 1994 through 2000. Previously, he was a Vice President for both Drexel Burnham Lambert and Donaldson Lufkin and Jenrette in Los Angeles, and he ran a private equity investment fund. Mr. Walters also serves as Chairman of the Board of Directors and Chief Executive of Management Energy, Inc., Monarch Staffing, Inc. and STI Group, Inc., as Chairman of the Board of Directors of Remote Dynamics, Inc., and a member of the Board of Directors of Trans-Pacific Aerospace Company, Inc. Mr. Walters earned a Bachelor of Science in Bioengineering from the University of California, San Diego.
Mr. Walters is Chairman of the Company’s Compensation Committee .and a member of the Company’s Audit Committee.
http://monarchbayassociates.com/investment-banking.htm
Bounce Mobile (BNCM)
http://ih.advfn.com/p.php?pid=squote&symbol=BNCM
Monarch Staffing (MSTF)
http://investorshub.advfn.com/boards/board.aspx?board_id=9690
Remote Dynamics (RMTD)
http://investorshub.advfn.com/boards/board.aspx?board_id=6762
STI Group (STUO)
http://investorshub.advfn.com/boards/board.aspx?board_id=15021
Apparently, many investors are not yet accepting the idea of a healthier Euro Zone.
Consider this fact: If you hold shares of WMT through 3/11/12 you will be paid as follows below. (annual yield 2.7% at Thursday close) Worth the price and the wait. You make the call.
1 share.......$ 0.39
10 shares......$ 3.97
100 shares......$ 39.75
1000 shares......$397.50
2000 shares......$795.00
Let the Euro Zone Love Fest begin! All together now; Kum bay ya, my Lord, Kum bay ya.......
EU Leaders Declare Crisis Turning Point in Shift to Growth
http://www.bloomberg.com/news/2012-03-02/eu-leaders-declare-crisis-turning-point-as-focus-starts-shifting-to-growth.html
While this seems positive for TBT in the short term, I'm still looking for the nearest lighted exit sign.
Most EU leaders sign treaty aimed at debt crisis
http://latimesblogs.latimes.com/world_now/2012/03/reporting-from-london-leaders-from-25-of-the-european-unions-27-countries-signed-a-new-treaty-on-fiscal-discipline-friday.html
Annual dividend increased to $1.59 per share
Next record date for quarterly payout of $0.3975 will be 3/11/2012 with pay date, 4/4/2012
http://investors.walmartstores.com/phoenix.zhtml?c=112761&p=irol-newsArticle&ID=1667930&highlight=
Fictional video speculating about a potential collapse of the dollar and how the early hours of such an event might play out.
http://www.youtube.com/embed/N3q5NyxI8nk
A nod's as good as a wink to a blind bat?
European Stocks Rise as ECB Long-Term Loans Exceed Forecasts; Holcim Gains
http://www.bloomberg.com/news/2012-02-29/european-stock-futures-advance-before-ecb-allots-long-term-loans-to-banks.html
How will the markets view QEES2? (Quantitative Easing, European Style 2) Please fasten your seat belts before the ride begins.
ECB loans out €529.5 billion to European banks
http://money.cnn.com/2012/02/29/markets/ecb_bank_loans/index.htm
Buzz in Alzheimer's Discussion Community
Is Bexarotene A Magical Cure for Alzheimer's, or a Magic Eraser
This week the Alzheimer's community is buzzing about a new research study published in Science Express that indicates amyloid plaque (Abeta) was removed from Alzheimer's infected mice in a few hours by an already existing, FDA approved drug, Bexarotene.
http://www.alzheimersreadingroom.com/2012/02/is-bexarotene-magical-cure-for.html
Since Alzheimer's would be a completely new indication, I believe there is a clear case for a patent extension, and, hopefully, Eisai will publicly clarify their patent related intentions in the near future. I strongly suspect public news releases will be a big part of any near term stock price movement regardless of how aggressive or successful any marketing strategies may be. In any case, hold on tight should the FDA announce "fast track" status for this already available drug.
EISAI (ESALY) DRUG, TARGRETIN - EXTRAPOLATION UP TO YOU
<Researchers identified a drug which, in animals, rapidly decreases both plaque area and soluble amyloid beta levels in mouse models of Alzheimer's disease. And it's FDA-approved.>
<The drug in question is Targretin (bexarotene, Eisai Inc.) which was approved for the treatment of cutaneous T-cell lymphoma in 2000.>
<When Landreth and his team treated several different mouse models of Alzheimer's disease with Targretin, levels of soluble amyloid beta decreased within six hours. The team tested their mice on several learning tasks; in some of those tasks, they saw improvements with as little as one week of treatment, though in others, longer treatment was necessary. The drug also improved the animals' olfactory abilities, which are normally impaired by plaque deposition. Finally, animals that had lost the ability to build nests – a social behavior for mice – were once again able to do so after Targretin treatment.>
<Although he has no solid proof, Landreth's hunch is that the drug's effectiveness at improving behavioral symptoms is in large part due to its effects on soluble amyloid beta, not plaques. "I think that as we pull down Abeta levels, synaptic function improves, and that subserves the improvement in behavior," he said.>
http://www.bioworld.com/content/eisai-lymphoma-drug-reverses-alzheimers-disease-symptoms-0
ESALY - Eisai
INVESTMENT IDEAS > BIOTECH
Biotech Ideas: Cancer Drug Reverses Alzheimer’s Symptoms in Mice
Targretin was found to significantly reduce beta amyloid plaque in the brains of mice with Alzheimer’s disease. Amyloid plaque buildup is the hallmark of Alzheimer’s disease in humans.
The drug is currently marketed by Eisai Co. as a skin cancer treatment, however the drug was shown to reduce amyloid buildup in the brains of mice by half in three days, according to Bloomberg.
http://wire.kapitall.com/investment-idea/biotech-ideas-cancer-drug-reverses-alzheimers-symptoms-in-mice/
FDA Accepts Resubmitted Application For Weight-Loss Drug Lorcaserin
Arena Pharmaceuticals Inc. (ARNA) and its partner, Eisai Co.'s (ESALY, 4523.TO) U.S. unit, said the U.S. Food and Drug Administration accepted their resubmitted new drug application for antiobesity drug lorcaserin.
Shares of Arena jumped 11% premarket to $1.78 as the biotechnology company said the FDA assigned a new Prescription Drug User Fee Act target date of June 27. The stock has gained 15% over the past three months through Monday's close.
The FDA requested in 2010 multiple sets of new data from Arena about lorcaserin, and the company said last week it submitted a response to the agency's two remaining concerns: the link between mammary tumors and a particular hormone in rats and deeper understanding about the drug's activity at three serotonin receptor subtypes.
Arena is one of three small drug developers that had its respective weight-loss pill candidates rejected by the FDA recently. Vivus Inc. (VVUS) and Orexigen Therapuetics Inc. (OREX) were also turned down by the agency, which raised major safety concerns about all three treatments. Vivus resubmitted its application in October, while Orexigen suspended development of its weight-loss drug Contrave.
Eisai's American depositary shares closed Monday at $40.76 and were inactive premarket.
-By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com
We could go either way today. It's a toss up.
Shares, euro firmer but growth worries lurk
(Reuters) - European shares rose on Friday and the euro hit fresh highs against the dollar as investors focused on bright spots in the global growth outlook, but unease about soaring oil prices and implementation of Greece's rescue deal tempered risk appetite.
http://www.reuters.com/article/2012/02/24/us-markets-global-idUSTRE8181RD20120224
Just received upgrade notice on WMT from my fee for service financial adviser. It went from A- to A+. Interesting, given the current mood in the markets.
115,300,000 shares repurchased at average share price $54.64
During the fourth quarter, the company repurchased approximately 22.9 million shares for $1.3 billion, bringing the full year repurchases to 115.3 million shares for $6.3 billion. In addition, the company paid $1.2 billion and $5.0 billion in dividends for the quarter and year, respectively. For the year, Walmart returned $11.3 billion to shareholders through dividends and share repurchases.
http://ih.advfn.com/p.php?pid=nmona&article=51280462&symbol=WMT
Exactly, and although there are seemingly endless challenges in the current economic environment, Walmart continues to find ways to succeed. Furthermore, the massive and continuing share buyback program is possibly being overlooked by many investors and analysts.
Wal-Mart Announces $15 Billion Stock Buyback (June 3, 2011)
In a big splash at its annual meeting, Wal-Mart announced a $15 billion stock buy back.
Zuma Press
UPDATE: The announcement, reported earlier by CNBC, is helping make Wal-Mart one of just two Dow 30 components in positive stock territory today. (The other is J.P. Morgan.) Wal-Mart is barely in the red, up 7 cents to $53.62 in recent trading.
A year ago, the world’s largest company also approved a $15 billion stock buyback program. According to the retailer’s annual report, it repurchased about $14.8 billion worth of its own stock in the year ended Jan. 31, 2011.
As our corporate cousins at Barron’s recently noted, Wal-Mart’s earnings per share have gotten a lift from a heady stream of repurchases of Wal-Mart’s own stock. Of course, Wal-Mart could use a lift by any means necessary. The retailer has been posting persistent declines in its U.S. store sales.
Wal-Mart Financial Chief Charles Holley is crowing at the annual meeting about the company’s improved earnings per share in the last fiscal year. No mention of the earnings boost from the buybacks.
http://blogs.wsj.com/deals/2011/06/03/wal-mart-announces-15-billion-stock-buyback/
I absolutely agree for the the long run, but I'm beginning to think there's more significant bad economic news coming for the Euro zone, and, in the short run, such a scenario will likely not bode well for TBT. Of course, I could be wrong, but Euro-zone unity seems to be deteriorating at a more rapid rate than I previously envisioned. If true, the discord and chaos will likely extend the short term benefit to U.S. debt for a little longer. I'm just saying we may be in for a little longer wait on this anticipated TBT explosion, but I do continue to believe we are at a fairly solid bottom here.
Caution: Investors may not be "buying" the "bailout".
Europe seals new Greek bailout, doubts remain
Many economists question whether Greece can pay off even a reduced debt burden, suggesting the deal may only delay a deeper default by a few months.
http://www.reuters.com/article/2012/02/21/us-greece-idUSTRE8120HI20120221
Opportunity for cheaper shares prior to the ex-dividend date?
Wal-Mart Fourth-Quarter Profit Trails Estimates as Low Prices Hurt Margins
http://www.bloomberg.com/news/2012-02-21/wal-mart-fourth-quarter-profit-trails-estimates-as-low-prices-hurt-margins.html
Wal-Mart Stores, Inc. : Walmart reports Q4 EPS from continuing operations of $1.51; Walmart U.S. delivers positive traffic and positive comp sales in Q4
Q4 highlights:
Walmart reported fourth quarter diluted earnings per share from continuing operations (EPS) of $1.51, which included net benefits of approximately $0.07 from certain tax matters and real estate transactions. The company's EPS guidance for the quarter of $1.42 to $1.48 did not include these net benefits. This EPS compared to $1.41 last year, which included net tax benefits of approximately $0.07.
Consolidated net sales for the fourth quarter were $122.3 billion, an increase of 5.8 percent from last year.
Walmart U.S. reported positive comparable traffic, and comparable store sales rose 1.5 percent in the 13-week period ended Jan. 27, 2012.
http://www.4-traders.com/WAL-MART-STORES-INC-4841/news/WAL-MART-STORES-INC-Walmart-reports-Q4-EPS-from-continuing-operations-of-$1-51-Walmart-U-S-deliver-14032954/
"The Beat Goes On"
Europe seals new Greek bailout to avert default
The euro gained in Asia after the bailout was agreed.
http://www.reuters.com/article/2012/02/21/us-greece-idUSTRE8120HI20120221
Yihaodian is one of the fastest growing companies in China, and has earned first place for Deloitte Technology Fast500 Asia Pacific and first place for China Entrepreneur Magazine's Future Stars of China Enterprises in 2011
Walmart Global eCommerce Announces Increased Investment in Yihaodian
http://ih.advfn.com/p.php?pid=nmona&article=51260178&symbol=WMT
Happy President's Day!
Shares, euro gain on China easing, Greek hopes
(Reuters) - European shares hit seven-month highs and the euro rose on Monday, underpinned by a surprise stimulus move in China and signs Greece would secure a long-awaited bailout deal, though rising oil prices weighed on sentiment.
http://www.reuters.com/article/2012/02/20/us-markets-global-idUSTRE8181RD20120220
this study is promising – so promising that the Alzheimer’s Association will be funding the next step in understanding the mechanisms behind the study.
Research on skin cancer drug shows possible benefit in Alzheimer’s
http://www.alznorcalblog.org/2012/02/09/research-skin-cancer-drug-shows-benefit-alzheimers/
To everything, there is a season.
T. Boone Pickens: Natural Gas a Game-Changer
http://www.cnbc.com/id/46403675
Iranian tensions, Europe weather raise price of oil
http://www.azcentral.com/arizonarepublic/business/articles/2012/02/16/20120216iranian-tensions-europe-weather-raise-price-oil.html
News? We don't need no stinkin' news!
Anyone else getting dizzy?
Europe stocks rise on Greek hopes, U.S. data
Banks lead gains as Greece gets closer to bailout approval
http://www.marketwatch.com/story/europe-stocks-rise-on-greek-hopes-us-data-2012-02-17?dist=beforebell
Since Targretin (bexarotene) is already on the market, aren't physicians going to try it out of compassion in certain Alzheimer's patients? What about the high cost? The buzz should start picking up very soon IMHO.
http://dementianews.wordpress.com/2012/02/15/alzheimers-brain-plaques-rapidly-cleared-by-cancer-drug-in-mice-bbc-news-nhs-choices/
http://abcnews.go.com/Health/AlzheimersCommunity/alzheimers-disease-skin-cancer-drug-sparks-hope-desperation/story?id=15573971#.TzvGY83y-pY
Whew! I'm glad they delayed the 10K for a few days so everyone could stock up on personal lubricant.
Never forget the "Subsequent Events"!
NOTE 12 – SUBSEQUENT EVENTS
Events subsequent to October 31, 2011 have been evaluated through the date these financial statements were issued, to determine whether any events should be disclosed to keep the financial statements from being misleading. The following event occurred since October 31, 2011:
· On November 15, 2011, the Company issued 3,500,000 common shares to the Company’s Board of Directors for services. The shares were valued at $367,000 based on the closing stock price on the date of the restricted stock grant.
· On November 15, 2011, the Company issued 1,000,000 shares of its common stock to Theodora Kobal, a related party, as reimbursement for transfer of her free trading stocks to Equiti-Trend.
· On December 13, 2011, the Company issued 1,500,000 shares of its common stock to an accredited investor at $0.05 per share for a total of $75,000 in cash.
· On December 21, 2011, the Company issued 1,000,000 shares of its common stock to Checkpoint Marketing, Inc. in lieu of finders fee.
Liquidity and Capital Resources
As of October 31, 2011, we had total assets of $43,061 and a working capital deficit of $477,998. Since October 31, 2011, our working capital has decreased as a result of continuing losses from operations. We estimate that we require approximately $2 million of additional working capital over the next 12 months in order to fund our expected marketing and distribution of the initial line of aircraft component products to be manufactured by Godfrey and to fund our expected operating losses as we endeavor to build revenue and achieve a profitable level of operations. However, there are no commitments or understandings at this time with any third parties for their provision of capital to us.
We will endeavor to raise the additional required funds through various financing sources, including the sale of our equity and debt securities and, subject to our commence of significant revenue producing operations, the procurement of commercial debt financing. However, there can be no guarantees that such funds will be available on commercially reasonable terms, if at all. If such financing is not available on satisfactory terms, we may be unable to expand or continue our business as desired and operating results may be adversely affected. In addition, any financing arrangement may have potentially adverse effects on us or our stockholders. Debt financing (if available and undertaken) will increase expenses, must be repaid regardless of operating results and may involve restrictions limiting our operating flexibility. If we issue equity securities to raise additional funds, the percentage ownership of our existing stockholders will be reduced and the new equity securities may have rights, preferences or privileges senior to those of the holders of our common stock.
The report of our independent registered public accounting firm for the fiscal year ended October 31, 2011 states that due to our losses from operations and lack of working capital there is substantial doubt about our ability to continue as a going concern.
http://ih.advfn.com/p.php?pid=nmona&article=51153627
Results of Operations - Years Ended October 31, 2011 and 2010
We have not commenced revenue producing operations and do not expect to until the fourth quarter of 2012, at the earliest, at which time we expect to commence the distribution of Godfrey’s line of spherical bearings. During the 2011 fiscal year, we incurred $2,923,603 of expenses compared to $2,374,259 during fiscal 2010. Our operating expenses consist primarily of general and administrative expenses and the increase in operating expenses from fiscal 2010 to fiscal 2011 was attributable primarily to increase in stock based compensation, professional, and consulting fees. We expect our operating expenses will significantly increase at such time as we commence the distribution of Godfrey’s spherical bearings.
During the 2011 fiscal year, we incurred a net loss from continuing operations of $3,040,825 compared to a net loss from continuing operations of $5,050,612 during fiscal 2010. The decrease in our net loss in 2011 was attributable primarily to the $2,469,404 of charges in 2010 relating to the impairment of the assets we acquired from Harbin Aerospace Company, LLC in February 2010 offset by the increase in stock based compensation, professional, and consulting fees in fiscal 2011. We acquired from Harbin certain intangible intellectual property, including blueprints, formulas, designs and processes, for manufacturing and production of self-lubricated spherical bearings, bushings and rod-end bearings. The transaction was deemed to be a business combination pursuant to the FASB standards. We perform an annual review for impairment of our intangible assets, and at an annual review at October 31, 2010 it was determined that the Harbin intellectual property was fully impaired, resulting in an impairment charge in fiscal 2010 of $2,469,404.
http://ih.advfn.com/p.php?pid=nmona&article=51153627
10Q out and TPAC is still growing!
State the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date: 61,169,244 shares as of January 23, 2012.
Shares Outstanding
5,280,000 05/08/2008
5,280,000 06/10/2008
15,840,000 09/08/2008
15,840,000 01/20/2009
15,840,000 02/25/2009
15,840,000 05/31/2009
11,165,000 09/16/2009 (Monarch Bay Way Kicks In)
23,201,937 02/10/2010
23,293,937 03/12/2010
26,729,937 06/17/2010
29,393,586 10/20/2010
37,000,286 02/11/2011
41,760,286 03/14/2011
45,960,546 06/10/2011
49,282,546 09/14/2011
61,169,244 01/23/2012
Into the valley of Death
Rode the six hundred.
Greek Conservative Leader Sends Bailout Commitment Letter
http://www.foxbusiness.com/markets/2012/02/15/greek-conservative-leader-bailout-commitment-letter-coming-soon/
China to the rescue!
Euro Strengthens as China Pledges Assistance; Dollar, Yen Weaken
http://www.businessweek.com/news/2012-02-15/euro-strengthens-as-china-pledges-assistance-dollar-yen-weaken.html
The 10Q was quite disappointing, but we probably should have anticipated some level of bad news with the U.S. Defense Budget under attack from every angle and so much uncertainty in the overall markets. Still, what an ugly day for EKCS!
Final Jeopardy (please place your wager)
Euro zone puts Greek plan under microscope
Euro zone analysing Greece's budget commitments
* Finance ministers expected to approve new package on Wed
* New, 130 bln euro package may be paid only in stages
http://www.reuters.com/article/2012/02/14/eurozone-greece-eurogroup-idUSL5E8DE6YM20120214
Well, it looks like the overall European situation has deteriorated on some additional fronts, and the daily ups and downs in Greece may have temporarily lost some impact here. I think most informed investors believe the Euro is ultimately doomed and these short term fixes are just that - SHORT TERM. Even so, I think there will be numerous short-lived rallies for TBT, as each European "fix" is thrown on the table, creates false optimism, then quickly fails. After all, we are basically betting on financial failure here, and the prospects for that eventuality in Europe AND the U.S, seem fairly certain to me. Additionally, I think we are arguably at a pretty hard bottom for TBT (at yesterday's level) and regardless of the timeline for the Euro deathwatch, it seems very likely the current European troubles are headed to the U.S. in the near future.
Greece rushes to meet lender demands
http://www.reuters.com/article/2012/02/14/greece-idUSL5E8DD8I020120214
German Investor Confidence at 10-Month High
http://www.bloomberg.com/news/2012-02-14/german-investor-confidence-jumps-to-10-month-high-after-debt-crisis-eases.html
Spain gets the worst of fresh Moody’s cuts
Triple-A France, Britain, Austria outlooks cut to negative
http://www.marketwatch.com/story/moodys-downgrades-spain-portugal-italy-2012-02-14?dist=beforebell
Obama Announces $3.8 Trillion Budget
http://wire.inc.com/2012/02/13/obama-announces-3-8-trillion-budget/